Lemaitre Vascular Inc - Post-Effective Amendment to an S-8 filing (S-8 POS)
July 02 2008 - 6:52AM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on July 2, 2008
Registration No. 333-146395
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT
TO
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES
ACT OF 1933
LeMaitre Vascular, Inc.
(Exact Name
of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation or Organization)
04-2825458
(I.R.S. Employer Identification No.)
LeMaitre Vascular, Inc.
63 Second Avenue
Burlington, Massachusetts 01803
(Address of Principal Executive Offices) (Zip Code)
LeMaitre Vascular, Inc. 401(k) Plan
(Full Title of the Plan)
|
|
|
George W. LeMaitre
Chairman and Chief Executive Officer
LeMaitre Vascular, Inc.
63 Second Avenue
Burlington,
Massachusetts 01803
(Name and Address of Agent for Service)
|
|
Copies to:
Michael H. Bison, Esq.
Goodwin Procter LLP
Exchange Place
Boston, Massachusetts 02109
(617) 570-1000
|
(781) 221-2266
(Telephone Number, Including Area Code, of Agent For Service.)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer,
accelerated filer and smaller reporting company in Rule 12b.
|
|
|
Large accelerated filer
¨
|
|
Accelerated filer
¨
|
Non-accelerated filer
¨
|
|
Smaller reporting company
x
|
EXPLANATORY NOTE
LeMaitre Vascular, Inc., a Delaware corporation (the Registrant), is filing this Post-Effective Amendment No. 1 to the Registration Statement on Form S-8 (the Post-Effective Amendment) in
connection with certain shares of the Companys common stock, par value $0.01 per share (the Common Stock), that were originally registered pursuant to the Registration Statement on Form S-8 filed with the Securities and Exchange
Commission on September 28, 2007, File No. 333-146395 (the Registration Statement) to be offered or sold under the LeMaitre Vascular, Inc. 401(k) Plan (the Plan). Pursuant to Rule 416(c) under the Securities Act of
1933, as amended (the Securities Act), the Registration Statement also covered an indeterminate amount of interests to be offered or sold pursuant to the Plan. This Post-Effective Amendment No. 1 is being filed to deregister all
shares of Common Stock that were covered by the Registration Statement but which have not been purchased under the Plan, and to remove from registration such indeterminate amount of Plan interests that remain unissued under the Plan.
Accordingly, the Registrant hereby withdraws from registration under the Registration Statement, all remaining shares of Common Stock that have not been
and will not be sold under the Plan.
2
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this
Post-Effective Amendment No. 1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Burlington, Commonwealth of Massachusetts, on July 2, 2008.
|
|
|
LEMAITRE VASCULAR, INC.
|
|
|
By:
|
|
/s/ George W. LeMaitre
|
|
|
George W. LeMaitre
Chairman and Chief Executive
Officer
|
Pursuant to the requirements of the Securities Act of 1933, as amended, this Post Effective
Amendment No. 1 to the Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
|
|
|
|
|
Signature
|
|
Title(s)
|
|
Date
|
|
|
|
/s/ George W. LeMaitre
George W. LeMaitre
|
|
Chairman, Chief Executive Officer and Director
(Principal Executive Officer)
|
|
July 2, 2008
|
|
|
|
/s/ David B. Roberts
David B. Roberts
|
|
President and Director
|
|
July 2, 2008
|
|
|
|
/s/ George D. LeMaitre
George D. LeMaitre
|
|
Director
|
|
July 2, 2008
|
|
|
|
/s/ Cornelia W. LeMaitre
Cornelia W. LeMaitre
|
|
Director
|
|
July 2, 2008
|
|
|
|
/s/ Lawrence J. Jasinski
Lawrence J. Jasinski
|
|
Director
|
|
July 2, 2008
|
|
|
|
/s/ David N. Gill
David N. Gill
|
|
Director
|
|
July 2, 2008
|
|
|
|
/s/ William N. Thorndike, Jr.
William N. Thorndike, Jr.
|
|
Director
|
|
July 2, 2008
|
3
LeMaitre Vascular (NASDAQ:LMAT)
Historical Stock Chart
From Jul 2024 to Jul 2024
LeMaitre Vascular (NASDAQ:LMAT)
Historical Stock Chart
From Jul 2023 to Jul 2024